Table 3 Presence of fecal S. lupi eggs and DNA based on sugar flotation and high-resolution melt real-time polymerase chain reaction, respectively, in dogs with naturally occurring esophageal spirocercosis treated with Advocate® or doramectin. Dogs number 2, 3, 5, 6, 7 were switched from Advocate® to doramectin treatment on week 12 and dog number 9 was switched from Advocate® to doramectin treatment on week 5
Week/ Dog ID | 1 | 2 | 3 | 4 | 6 | 8 | 12 | 16 | 20 |
|---|---|---|---|---|---|---|---|---|---|
FF/PCR | FF/PCR | FF/PCR | FF/PCR | FF/PCR | FF/PCR | FF/PCR | FF/PCR | FF/PCR | |
Advocate® (treatment) group | |||||||||
1 | +/na | +/+ | -/+ | +/+ | -/- | -/- | -/- | -/+ | -/- |
2 | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | -/+ | -/- |
3 | -/+ | +/- | -/+ | -/+ | -/- | -/- | -/- | -/- | -/- |
4 | +/+ | -/- | -/- | -/- | -/- | -/- | -/na | -/- | -/- |
5 | -/+ | -/- | +/- | -/- | -/- | -/- | -/- | -/- | -/- |
6 | -/- | -/+ | -/- | -/- | -/- | -/- | -/- | -/- | -/- |
7 | -/- | -/+ | -/- | +/+ | +/+ | +/+ | +/+ | -/+ | na/- |
8 | -/- | -/- | -/+ | -/- | -/- | -/- | -/- | -/- | -/- |
9 | -/+ | +/+ | -/+ | -/+ | -/+ | -/- | -/- | -/- | na/- |
10 | -/+ | -/+ | +/+ | -/+ | -/- | -/- | -/- | na/- | -/- |
Doramectin (control) group | |||||||||
11 | +/na | -/+ | -/- | -/+ | -/- | -/- | -/- | -/- | -/- |
12 | -/- | -/- | -/- | -/- | -/- | -/- | -/- | -/- | -/- |
13 | -/- | -/- | -/- | -/- | -/- | -/- | -/- | -/- | -/- |
14 | -/- | -/- | -/- | -/- | -/- | -/- | -/- | -/- | -/- |
15 | na/+ | -/- | -/- | -/- | -/- | -/- | -/- | -/- | -/- |
16 | +/+ | -/- | -/- | -/- | -/- | -/- | -/- | -/- | -/- |
17 | -/- | -/+ | -/+ | -/+ | -/- | -/- | -/- | -/- | -/- |
18 | na/+ | +/+ | -/- | +/na | -/- | -/- | -/- | -/- | -/- |
19 | -/- | -/- | -/- | -/- | -/- | -/- | -/- | -/- | -/- |
20 | -/na | -/- | -/- | -/- | -/- | -/- | -/- | -/- | na/- |